Solvay Reports a Fall in Profits and Sales

Solvay reported a 36% decrease in second-quarter 2009 net profits, to €83 million, compared with the corresponding period of 2008, on sales down 12%, to €2.06 billion. The Pharmaceuticals segment of Solvay recorded a 11% increase in sales for the second quarter, to €661 million, compared with the year-ago period. The recurring Ebit for the segment increased by 4%, to €115 million. The segment benefited from the sustained growth of certain drugs, the overall positive exchange rate effects and the continued improvement of sales from emerging...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers